0

Halopemide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP59831651
CAS59831-65-1
Structure
MDL NumberMFCD00866684
Molecular Weight416.88
InChI KeyNBHPRWLFLUBAIE-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: >10 mg/mL
Assay≥98% (HPLC)
Coloroff-white
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Determination of the Formation Rate of Phosphatidylethanol by Phospholipase D (PLD) in Blood and Test of Two Selective PLD Inhibitors

Alexandra Schröck, Anna Henzi, Peter Bütikofer, Stefan König, Wolfgang Weinmann

Alcohol. 2018 Dec;73:1-7.

PMID: 30103144

1

Effects of Halopemide, a New Psychotropic Agent, on the Uptake of Serotonin by Blood Platelets

A J Loonen, W Soudijn

Arch Int Pharmacodyn Ther. 1979 Feb;237(2):267-74.

PMID: 39525

1

Halopemide, a New Psychotropic Agent. Cerebral Distribution and Receptor Interactions

A J Loonen, W Soudijn

Pharm Weekbl Sci. 1985 Feb 22;7(1):1-9.

PMID: 2984638

1

Phospholipase D: A New Mediator During High Phosphate-Induced Vascular Calcification Associated With Chronic Kidney Disease

Najwa Skafi, Dina Abdallah, Christophe Soulage, Sophie Reibel, Nicolas Vitale, Eva Hamade, Wissam Faour, David Magne, Bassam Badran, Nader Hussein, Rene Buchet, Leyre Brizuela, Saida Mebarek

J Cell Physiol. 2019 Apr;234(4):4825-4839.

PMID: 30207376

1

Regional Localization of Halopemide, a New Psychotropic Agent, in the Rat Brain

A J Loonen, I van Wijngaarden, P A Janssen, W Soudijn

Eur J Pharmacol. 1978 Aug 15;50(4):403-8.

PMID: 29759

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode